Home/Filings/4/0001209191-13-053873
4//SEC Filing

PharMerica CORP 4

Accession 0001209191-13-053873

CIK 0001388195operating

Filed

Nov 24, 7:00 PM ET

Accepted

Nov 25, 9:31 AM ET

Size

10.3 KB

Accession

0001209191-13-053873

Insider Transaction Report

Form 4
Period: 2013-11-21
Transactions
  • Tax Payment

    Common Stock, $0.01 par value

    2013-11-21$20.70/sh12,153$251,56743,386 total
  • Sale

    Common Stock, $0.01 par value

    2013-11-22$20.56/sh3,271$67,24840,115 total
  • Exercise/Conversion

    Stock option (right to buy)

    2013-11-2115,4240 total
    Exercise: $16.31Exp: 2014-08-06Common Stock, $0.01 par value (15,424 underlying)
  • Exercise/Conversion

    Common Stock, $0.01 par value

    2013-11-21$16.31/sh+15,424$251,56555,539 total
Footnotes (2)
  • [F1]Represents the weighted average purchase price for the transactions reported on this line. The range of prices for the transactions reported on this line was $20.486 to $20.622. The reporting person will provide to the Commission, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price.
  • [F2]The options vested in the following amounts on the following dates: 5,141 options on 08/07/2008, 5,141 options on 08/07/2009 and 5,142 options on 08/07/2010.

Issuer

PharMerica CORP

CIK 0001388195

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001388195

Filing Metadata

Form type
4
Filed
Nov 24, 7:00 PM ET
Accepted
Nov 25, 9:31 AM ET
Size
10.3 KB